Judge Won't Cut Weisheng Parent From Vitamin C Cartel Case

Law360, New York (July 19, 2012, 9:32 PM EDT) -- A New York federal judge refused Wednesday to drop China Pharmaceutical Group Ltd. from multidistrict price-fixing litigation against several Chinese vitamin C producers, ruling that the company had enough control over its manufacturing subsidiary to remain in the case.

U.S. District Judge Brian M. Cogan denied a pair of long-outstanding motions from China Pharmaceutical to exit the case, based on the company's claims that the court lacked jurisdiction over it and that the plaintiffs couldn't prove it had attended any price-fixing meetings on its own behalf....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.